Float Short %

2.77

Margin Of Safety %

-32

Put/Call OI Ratio

0.53

EPS Next Q Diff

-0.14

EPS Last/This Y

5.93

EPS This/Next Y

0.78

Price

101.6

Target Price

102.82

Analyst Recom

2.73

Performance Q

75.98

Relative Volume

0.49

Beta

1.42

Ticker: EXAS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	EXAS	101.24	0.59	0.04	61836
2025-12-10	EXAS	101.25	0.58	0.05	62651
2025-12-11	EXAS	101.37	0.55	0.10	65087
2025-12-12	EXAS	101.51	0.55	4.85	65095
2025-12-15	EXAS	101.76	0.55	0.13	65160
2025-12-16	EXAS	101.75	0.55	0.04	65532
2025-12-17	EXAS	101.61	0.54	0.31	66001
2025-12-18	EXAS	101.36	0.54	0.41	66371
2025-12-19	EXAS	101.77	0.54	0.30	66781
2025-12-22	EXAS	101.76	0.54	0.16	60826
2025-12-23	EXAS	101.61	0.54	0.05	60854
2025-12-26	EXAS	101.57	0.54	0.06	61081
2025-12-29	EXAS	101.92	0.53	0.25	61428
2025-12-30	EXAS	101.91	0.53	0.09	61564
2025-12-31	EXAS	101.57	0.53	0.10	61719
2026-01-02	EXAS	101.72	0.53	0.01	62092
2026-01-05	EXAS	101.61	0.53	0.75	62143
2026-01-06	EXAS	101.64	0.53	0.80	62779
2026-01-07	EXAS	101.6	0.53	0.24	62825
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	EXAS	101.25	225.8	1180.4	0.34
2025-12-10	EXAS	101.25	225.8	1179.7	0.34
2025-12-11	EXAS	101.36	225.8	1180.0	0.34
2025-12-12	EXAS	101.52	225.8	1180.1	0.34
2025-12-15	EXAS	101.74	225.8	1180.3	0.34
2025-12-16	EXAS	101.74	225.8	1179.7	0.34
2025-12-17	EXAS	101.61	225.8	1179.5	0.34
2025-12-18	EXAS	101.38	225.8	1179.3	0.34
2025-12-19	EXAS	101.77	225.8	1180.6	0.34
2025-12-22	EXAS	101.75	225.8	1179.6	0.34
2025-12-23	EXAS	101.64	225.8	1179.4	0.34
2025-12-26	EXAS	101.58	225.8	1179.9	0.34
2025-12-29	EXAS	101.90	225.8	1180.5	0.34
2025-12-30	EXAS	101.92	225.8	1179.7	0.34
2025-12-31	EXAS	101.57	225.8	1179.1	0.34
2026-01-02	EXAS	101.72	225.8	1180.1	0.34
2026-01-05	EXAS	101.60	225.8	1179.5	0.34
2026-01-06	EXAS	101.65	225.8	1179.9	0.34
2026-01-07	EXAS	101.60	225.8	1179.7	0.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	EXAS	-0.98	-1.61	3.94
2025-12-10	EXAS	-0.98	-1.61	2.73
2025-12-11	EXAS	-0.98	-1.61	2.73
2025-12-12	EXAS	-0.98	-1.61	2.73
2025-12-15	EXAS	-0.98	-3.16	2.73
2025-12-16	EXAS	-0.99	-3.16	2.73
2025-12-17	EXAS	-0.89	-3.16	2.73
2025-12-18	EXAS	-0.89	-3.16	2.73
2025-12-19	EXAS	-0.89	-3.16	2.73
2025-12-22	EXAS	-0.89	-4.19	2.73
2025-12-23	EXAS	-0.89	-4.19	2.73
2025-12-26	EXAS	-0.89	-4.19	2.76
2025-12-29	EXAS	-0.89	-4.15	2.76
2025-12-30	EXAS	-0.89	-4.15	2.76
2025-12-31	EXAS	-0.89	-4.15	2.76
2026-01-02	EXAS	-0.89	-4.15	2.76
2026-01-05	EXAS	-0.89	-4.16	2.77
2026-01-06	EXAS	-0.73	-4.16	2.77
2026-01-07	EXAS	-0.73	-4.16	2.77
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.24

Avg. EPS Est. Current Quarter

0.08

Avg. EPS Est. Next Quarter

0.1

Insider Transactions

-0.73

Institutional Transactions

-4.16

Beta

1.42

Average Sales Estimate Current Quarter

860

Average Sales Estimate Next Quarter

831

Fair Value

69.2

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

36.3

Max Drawdown 5-Year %

-80.4

Target Price

102.82

P/E

Forward P/E

270.5

PEG

P/S

6.26

P/B

7.7

P/Free Cash Flow

78.12

EPS

-5.32

Average EPS Est. Cur. Y

0.34

EPS Next Y. (Est.)

1.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-32.01

Relative Volume

0.49

Return on Equity vs Sector %

-66.5

Return on Equity vs Industry %

-50.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1179.7

Exact Sciences Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 6900

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today

news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance

stock history EXAS – Exact Sciences Corporation invest stock market

stock prices EXAS premarket after hours

ticker EXAS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EXAS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y